About
Dr. John Liddicoat is a Senior Lecturer at King's College London's Dickson Poon School of Law and an Adjunct Research Fellow at the University of Tasmania. His Orcid identifier is 0000-0001-7370-3936. He holds dual expertise in law and genetics, with a focus on patent law’s role in technological innovation. He advises governments, international bodies (e.g., World Intellectual Property Organization), and pharmaceutical companies on intellectual property strategies.
Education includes a dual honors degree in Genetics and Law from the University of Melbourne (2009), followed by research roles at the Centre of Law and Genetics. His 2012 PhD thesis at UTAS analyzed patent infringement law using economic and comparative legal frameworks. He has held positions as a research associate and fellow, contributing to projects on patent pooling, genetic technologies, and 3D printing law.
Research interests span intellectual property in biotechnology, pharmaceuticals, and emerging technologies. Key projects include a £5.5M grant from the Novo Nordisk Foundation investigating AI/quantum tech intersections, sustainability, pandemic preparedness, and antimicrobial resistance. He co-authored a 2023 WHO report on patents and trade secrets in medical technologies, funded by the Wellcome Trust and Cancer Research UK.
Recent publications explore drug repurposing policies, AI in clinical trials, and patent eligibility in precision medicine. His work emphasizes empirical legal research to bridge doctrinal and economic analyses, informing innovation policy globally.
